Leukemia in Adults

Our experts use the latest techniques to diagnose and treat all forms of blood cancer, including leukemia, in which the abnormal growth of white blood cells causes cancer. We also treat neoplastic blood diseases, including myeloproliferative disorders and myelodysplastic syndromes, all of which are caused by an excessive growth of blood cells.

Through a collaborative approach, our multidisciplinary team of hematologists, oncologists, and pathologists provides personalized care and creates a treatment plan based on your particular diagnosis and individual needs.

To achieve the best possible outcomes, we offer the latest treatments, including chemotherapy, targeted therapy, stem cell transplants, epigenetic treatments, immunotherapy, and radiation therapy. Through clinical trials, our translational research program offers access to innovative treatments to patients. Our experts also work in close partnership with our Blood and Marrow Transplant Program to provide multiple treatment options.

Clinical Trials and Research Studies

Phase 2

A Phase IIa Open-label Clinical Trial to Evaluate the Safety Pharmacokinetics Pharmacodynamics and Efficacy of BP1001 (a Liposomal Grb2 Antisense Oligonucleotide) in Combination with Venetoclax plus Decitabine in Patients with Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Induction Therapy

Learn More

Phase 3

AALL1631: International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones

Learn More

Phase 6

AALL1931: JZP458-201: An Open Label Multicenter Study of RC-P in Patients with Acute Lymphoblastic Leukemia ALL/Lymphoblastic Lymphoma LBL Following Hypersensitivity to E. coli-derived Asparaginases

Learn More

Phase 3

A phase 3 randomized trial for patients with de novo AML comparing standard therapy including gemtuzumab ozogamicin GO to CPX-351 with GO and the addition of the FLT3 inhibitor gilteritinib for patients with FLT3 mutations

Learn More